Leiomyoma of the prostate: A case report and literature review
Zejun Liu,Ji Lu,Kai Yu,Tengteng Jian,Rui Hu,Min Liu
DOI: https://doi.org/10.1097/md.0000000000040340
IF: 1.6
2024-11-06
Medicine
Abstract:Leiomyomas are benign tumors that can develop in any organ, with the uterus being the most common site. The prevalence of leiomyomas in women can reach as high as 70% to 80% by the age of 50, with the highest incidence among women of African descent. [ 1 ] Leiomyomas originating in the bladder are rare, representing only 0.05% of all bladder tumors, with approximately 250 cases reported globally, affecting men and women equally. Even fewer leiomyomas originate in the prostate, with fewer than 100 documented cases worldwide to date. Most leiomyomas are diagnosed postoperatively, though they may also present with symptoms of local irritation, such as urinary retention, irritative urethral symptoms, and hematuria. The prognosis for leiomyomas is generally positive, with a low recurrence rate. However, accurately assessing the tumor's origin, size, and boundaries via ultrasound, CT, or MRI is often challenging. Moreover, no clinical guidelines have been established for diagnosing and managing this condition or for distinguishing it from malignant bladder tumors. In this report, we describe a case of prostate leiomyoma in a 51-year-old male patient. Additionally, we review the available literature on prostate leiomyomas, covering their epidemiology, etiology, clinical presentation, imaging characteristics, and the diagnostic and therapeutic approaches used in the differential diagnosis and treatment of this condition in clinical practice.
medicine, general & internal